The Efficiency for Stage II-III HR+/HER2+ Early Breast Cancer Patient With Standard Neoadjuvant Therapy in Real World.
Clinical trial NCT05263570 · RECRUITING
Trial details
- NCT number
- NCT05263570
- Sponsor
- Shengjing Hospital
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-08-01
- Primary completion
- 2023-12-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.